|
|
| On Line Home Study Programs |
|
The Dimension of Prevention:
Practical Approaches to Post Exposure Prophylaxis
Program Overview
To distinguish the need and appropriateness of active and passive immunization in disease states with both immune globulin and vaccine/toxoid availability.
Presentation
The program can be completed by viewing the PowerPoint® slide show (using Microsoft® PowerPoint® 97 or later), answering the post-test questions and completing the program evaluation on line. Statements of credit can be printed after successful completion of the program.
Program Information
- Target Audience
All Registered Pharmacists.
This program is not accredited for Pharmacy Technicians.
- Learning Objectives
After participating in this program, the pharmacist should be able to:
- Differentiate events and exposures that require post exposure prophylaxis from those that do not.
- Summarize the characteristics and qualities of active and passive immunization.
- Evaluate the need for the administration of passive immunity.
- Given a patient case, determine appropriate post exposure prophylaxis therapy.
Program Faculty
- Faculty Disclosure Statement
In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, Northeastern University Bouvé College of Health Sciences School of Pharmacy requires that faculty members disclose any relationship (e.g., shareholder, recipient of research grant, consultant, or member of an advisory committee) that the faculty may have with commercial companies whose products or services may be mentioned in their presentations. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on faculty presentations.
- Faculty and Disclosure Information
John Marshall, PharmD, BCPS
Clinical Specialist in Critical Care
Boston Medical Center, Boston, MA
- Has no actual or potential conflict in relation to this program.
- Does not plan on discussing unlabeled/investigational uses of a commercial product.
Program Support
Initially presented during the 2004 ASHP Midyear Clinical Meeting in Orlando, this course has been developed through the Northeastern University Bouve College of Health Sciences School of Pharmacy. It is supported by a grant from Talecris Biotherapeutics, in conjunction with ASD Healthcare.
There is no fee for this program.
Continuing Education Accreditation Information
Northeastern University Bouvé College of Health Sciences School of Pharmacy is approved by the Accreditation Council on Pharmacy Education as a provider of continuing pharmacy education. Pharmacists successfully participating in this program will receive a statement of credit for one contact hour (0.1 CEU). Statements of Credit may be printed on-line after successful completion of the learning assessment (70%).
ACPE #027-000-05-058-H01. Initial release date July 1, 2005, Expires July 1, 2008.
Further Disclosure of Unlabeled Use and Disclaimer
|
|
|
